Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Breast Neoplasms 2400Neoplasms 1817Carcinoma, Non-Small-Cell Lung 1598Prostatic Neoplasms 1306Colorectal Neoplasms 1139Lung Neoplasms 985Neoplasm Metastasis 836Multiple Myeloma 794Leukemia, Myeloid, Acute 767Ovarian Neoplasms 677Pancreatic Neoplasms 662Melanoma 660Squamous Cell Carcinoma of Head and Neck 584Carcinoma, Hepatocellular 571Recurrence 564Brain Neoplasms 528Glioblastoma 515Head and Neck Neoplasms 503Stomach Neoplasms 498Triple Negative Breast Neoplasms 465Lymphoma 456Uterine Cervical Neoplasms 453Carcinoma, Renal Cell 424Precursor Cell Lymphoblastic Leukemia-Lymphoma 408Lymphoma, Non-Hodgkin 390Endometrial Neoplasms 384Sarcoma 371Lymphoma, Follicular 358Urinary Bladder Neoplasms 355Hematologic Neoplasms 355

Interventions

trametinib 1selpercatinib 1pralsetinib 1lenvatinib 1larotrectinib 1entrectinib 1dabrafenib 1anlotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Thyroid Cancer Patients Who Received Target Therapy × 1 year × Clear all
NCT06195228 2025-08-14

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Fudan University

Phase 4 Recruiting
800 enrolled
EndocrineHead & Neck

Advanced Thyroid Cancer Patients Who Received Target Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡